COVID-19 Vaccine: Drug Controller General India hints close to approval

Must Read

NOTCHWEB’ S NIKHIL DARJI SAYS STARTUP SHOULD INVEST ON DIGITAL MARKETING OVER TRADITIONAL MARKETING

If you’re not very intimate with digital marketing, you might be suspicious of its value for your business. According...

The Journey Of Two Digitalites Gulrez Alam And Md Badshah Ansari – From Being Newbies To helping Newbies Revamp Their Digital Business

“If you don’t build your dream, someone else will hire you to help them build theirs.” The above mentioned famous...

Dan Ricco replaced by John Ternus during the latest Apple Exec shuffle

Dan Ricco, Apple’s senior vice-president of hardware engineering since 2012, transition to “a new role” at the company as...

After all the worst things happening around COVID-19 vaccine is the only hope left out there. V.G. Somani, Drug Controller General India (DCGI), at a webinar on Thursday indicated that India was close to approving a COVID-19 Vaccine.

Mr. Somani was participating in a webinar, organised by the Department of Biotechnology that saw vaccine experts, infectious disease experts, and representatives of companies developing vaccines discussing COVID-19 vaccine development and India’s preparation.

“We will probably have a Happy New Year with something in hand,” he said while discussing the regulatory process as well as the participation by academics, industry, and infectious disease experts in working towards developing vaccine candidates.

COVID-19 Vaccine: Drug Controller General India hints close to approval
The Quint

On Friday, the Subject Expert Committee, which is an expert body of the DCGI, that is pursuing applications by companies developing vaccines in India, is expected to review applications by companies developing vaccines in India, is expected to review applications by the Serum Institute of India (SII) and Bharat Biotech (BB) for emergency use authorisation. Under this, companies are given permission to market the vaccine; even if they haven’t furnished all the evidence normally required to establish; the product’s safety and efficacy.

SII has partnered with AstraZeneca; to bring to market the Oxford vaccine, which has been approved by health authorities in the United Kingdom; on Wednesday. Both SII and BB are testing the COVID-19 Vaccine; in ongoing phases-3 trials in India, the results of which have not been publicised yet.

Prime Minister Narendra Modi on Thursday also suggested that a vaccine was at hand.

Starting that India is getting ready to run the world’s largest vaccination programme, the Prime Minister said India has turned into the nerve-centre of global health. He also cautioned against rumours about the COVID-19 vaccination.

He said, “Different people for their personal gains or due to irresponsible behaviour spread various rumours. Maybe rumours will be spread when vaccination begins, some have already begun. I appeal to the people of the country that the fight against COVID-19 is the one against an unknown enemy. Be careful about such rumours and as responsible citizens refrain from forwarding messages on social media without checking.”

 

Latest News

Marco Polo Season 3: What Is Happening With The Show?Release Date And Updates

American show Marco Polo Season 3 is at present hanging between individuals' convictions and makers' goals. The keep going...